Friday, February 02, 2018 5:41:36 PM
• Company's sidestep federal legal issues by focusing on federally legal cannabidiol (CBD) and sourcing hemp grown outside the U.S.
• Company's target burgeoning cannabis market, in which CBD alone is anticipated to surpass $2 billion by 2020
• Product distribution in all 50 states and increasing internationally
Market Outlook
In the United States, more than 1.2 million people use cannabis to address various medical problems, ranging from depression to cancer and epilepsy. Despite legalization in various states, cannabis use is currently illegal at the federal level. However, CBD made from hemp sourced outside the U.S., and the resulting CBD-rich oils are 100 percent legal to sell in the United States. HMPQ "ROCKET TIME"
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM